The Gut Microbiome Affects Atherosclerosis by Regulating Reverse Cholesterol Transport

Overview

Journal J Cardiovasc Transl Res

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2024 Jan 17

PMID 38231373

Authors

Yangyang Jiang

Shuchao Pang

Xiaoyu Liu

Lixin Wang

Yi Liu

Affiliations

Soon will be listed here.

Abstract

The human system's secret organ, the gut microbiome, has received considerable attention. Emerging research has yielded substantial scientific evidence indicating that changes in gut microbial composition and microbial metabolites may contribute to the development of atherosclerotic cardiovascular disease. The burden of cardiovascular disease on healthcare systems is exacerbated by atherosclerotic cardiovascular disease, which continues to be the leading cause of mortality globally. Reverse cholesterol transport is a powerful protective mechanism that effectively prevents excessive accumulation of cholesterol for atherosclerotic cardiovascular disease. It has been revealed how the gut microbiota modulates reverse cholesterol transport in patients with atherosclerotic risk. In this review, we highlight the complex interactions between microbes, their metabolites, and their potential impacts in reverse cholesterol transport. We also explore the feasibility of modulating gut microbes and metabolites to facilitate reverse cholesterol transport as a novel therapy for atherosclerosis.

Citing Articles

Vascular medicine in the 21 century: Embracing comprehensive vasculature evaluation and multidisciplinary treatment.

Chaiter Y, Fink D, Machluf Y World J Clin Cases. 2024; 12(27):6032-6044.

PMID: 39328850 PMC: 11326099. DOI: 10.12998/wjcc.v12.i27.6032.

References

Berg G, Rybakova D, Fischer D, Cernava T, Verges M, Charles T . Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020; 8(1):103. PMC: 7329523. DOI: 10.1186/s40168-020-00875-0. View

Tang W, Hazen S . The Gut Microbiome and Its Role in Cardiovascular Diseases. Circulation. 2017; 135(11):1008-1010. PMC: 5354081. DOI: 10.1161/CIRCULATIONAHA.116.024251. View

Mistry R, Verkade H, Tietge U . Reverse Cholesterol Transport Is Increased in Germ-Free Mice-Brief Report. Arterioscler Thromb Vasc Biol. 2017; 37(3):419-422. DOI: 10.1161/ATVBAHA.116.308306. View

Haraszthy V, Zambon J, Trevisan M, Zeid M, Genco R . Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000; 71(10):1554-60. DOI: 10.1902/jop.2000.71.10.1554. View

Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A . Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease. J Atheroscler Thromb. 2016; 23(8):908-21. PMC: 7399299. DOI: 10.5551/jat.32672. View

Gozd-Barszczewska A, Koziol-Montewka M, Barszczewski P, Mlodzinska A, Huminska K . Gut microbiome as a biomarker of cardiometabolic disorders. Ann Agric Environ Med. 2017; 24(3):416-422. DOI: 10.26444/aaem/75456. View

Jie Z, Xia H, Zhong S, Feng Q, Li S, Liang S . The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017; 8(1):845. PMC: 5635030. DOI: 10.1038/s41467-017-00900-1. View

Granado-Serrano A, Martin-Gari M, Sanchez V, Riart Solans M, Berdun R, Ludwig I . Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia. Sci Rep. 2019; 9(1):1772. PMC: 6370822. DOI: 10.1038/s41598-019-38874-3. View

GOFMAN J, Young W, Tandy R . Ischemic heart disease, atherosclerosis, and longevity. Circulation. 1966; 34(4):679-97. DOI: 10.1161/01.cir.34.4.679. View

10.

Glomset J . The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968; 9(2):155-67. View

11.

Rosenson R, Brewer Jr H, Davidson W, Fayad Z, Fuster V, Goldstein J . Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation. 2012; 125(15):1905-19. PMC: 4159082. DOI: 10.1161/CIRCULATIONAHA.111.066589. View

12.

Shah A, Tan L, Long J, Davidson W . Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond. J Lipid Res. 2013; 54(10):2575-85. PMC: 3770071. DOI: 10.1194/jlr.R035725. View

13.

Bojanovski D, GREGG R, Ghiselli G, Schaefer E, Light J, BREWER Jr H . Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I. J Lipid Res. 1985; 26(2):185-93. View

14.

Allen P . The effect of Eimeria acervulina infection on plasma lipids and lipoproteins in young broiler chicks. Vet Parasitol. 1988; 30(1):17-30. DOI: 10.1016/0304-4017(88)90139-2. View

15.

Pownall H, Rosales C, Gillard B, Gotto Jr A . High-density lipoproteins, reverse cholesterol transport and atherogenesis. Nat Rev Cardiol. 2021; 18(10):712-723. DOI: 10.1038/s41569-021-00538-z. View

16.

Rye K, Hime N, Barter P . Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion. J Biol Chem. 1997; 272(7):3953-60. DOI: 10.1074/jbc.272.7.3953. View

17.

Settasatian N, Duong M, Curtiss L, Ehnholm C, Jauhiainen M, Huuskonen J . The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J Biol Chem. 2001; 276(29):26898-905. DOI: 10.1074/jbc.M010708200. View

18.

Lie J, de Crom R, Jauhiainen M, van Gent T, van Haperen R, Scheek L . Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins. Biochem J. 2001; 360(Pt 2):379-85. PMC: 1222238. DOI: 10.1042/0264-6021:3600379. View

19.

Bruce C, Sharp D, Tall A . Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res. 1998; 39(5):1071-8. View

20.

Kuwano T, Bi X, Cipollari E, Yasuda T, Lagor W, Szapary H . Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport. J Lipid Res. 2017; 58(4):731-741. PMC: 5392748. DOI: 10.1194/jlr.M074625. View